GlaxoSmithKline on its remote desktop interface for independent reanalysis of drug trial data

We launched our system in May 2013 to provide researchers with access to patient level data from our studies in the belief that greater access to these data would facilitate further research to advance medical science and lead to improvements in patient care. I am sorry that Jureidini and his team have had difficulty working within the system.1 We worked hard to …